U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump

Reuters |
Published: 11.22.20 , 13:34
The U.S. Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.